FTSE 100 retreats as US jobs growth surprises on the downside
Blue-chip stocks just about held on to some gains after the US jobs report came in weaker than expected
Company
Tissue Regenix Group PLC
LON:TRX
Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.
255 stories · page 10 of 13
Tissue Regenix resumes talks over Cellright acquisition as order lifted
Tissue said talks are ongoing but there is no certainty a deal will be agreed.
Tissue Regenix in talks to buy US rival Cellright
There was no certainty yet that the acquisition will go ahead
Investments and investor services
FTSE up with copper, FTSE 250 marks record 19,000 as Scots want referendum
Around 3.30pm, the FTSE 100 index was up almost 28 points at 7,371, just below the day’s best level of 7,376, having only hit a low of 7,342
Tissue Regenix Group receives US endorsement for DermaPure, its wound care product
The regenerative medical devices specialist has been awarded an innovative technology contract from Vizient, the largest member-owned health care company in the US.
Proactive news highlights: Mikango Resources, NetPlay, Plexus and more
Also covered: CloudTag, Green Dragon Gas, Hummingbird, Real Good Food, SDX, Stratmin, Sula, Sirius Minerals and Tissue Regenix
Tissue Regenix ’s skin graft to be available on US veterans network
The FSS group is the largest integrated healthcare system in the US covering almost 9mln people
Archive
Proactive news round-up: Satellite Solutions Worldwide, C4X Discovery, Tissue Regenix …
A glance at some of the stories on the Proactive newswire today
Tissue Regenix appoints group finance director
Paul Devlin brings a wealth of experience that will be invaluable to the company as it ups its commercial activity
Archive
Proactive news highlights: ImageScan swings to a profit
Elsewhere, Asiamet Resources raises £2mln; Berkeley Energia adds another piece to the Salmanca puzzle; Tissue Regenix opens another door in the US; plus much more…
Tissue Regenix inks deal with US healthcare group
Almost 125,000 hospitals and healthcare providers in the US will now have contracted access to DermaPure
Archive
Proactive news highlights: Active Energy lands financing for first CoalSwitch plant
Elsewhere, Haydale Graphene agrees a development deal with Araldite maker; Akers Biosciences hails its “highly successful” diabetes trial; Tissue Regenix signs it first European distribution agreements; plus much more…
Hotel Chocolat's rent record boosts Capital & Counties
Tissue Regenix and BOS GLOBAL both added to their recent gains
Tissue Regenix signs first European distribution deals for knee repair treatment
Data from OrthoPure XT has shown “a statistically significant improvement” in patients compared with the current gold standard
Tissue Regenix chief financial officer to move on
Jefferson will remain available to the regenerative medical devices company while the search for his successor takes place
Proactive news summary – Mirada, Tissue Regenix, Synairgen and Vast Resources
A selection of the day's significant news stories from the junior AIM market
Tissue Regenix making inroads in the US wound-care market
A twofold increase in US sales caught the eye, but the company is also poised to launch its first orthopaedic product in Europe.
Tissue Regenix: Pig tissue and cutting-edge medical science
The treatment involves removing cellular material from animal and human tissue to leave a matrix which gives a framework for population by the patient’s own cells.